RNS Number : 8414Y
JPMorgan European Grwth & Inc PLC
10 September 2025
| JPMORGAN EUROPEAN GROWTH & INCOME PLC (the 'Company') |
|
| Legal Entity Identifier: 549300D8SPJFHBDGXS57 |
|
| THE COMPANY ANNOUNCES THE TEN LARGEST INVESTMENTS IN % OF TOTAL ASSETS As at: 31 August 2025 |
|
| Novartis |
3.4% |
| Sap |
3.1% |
| Asml |
3.0% |
| Roche Holdings |
2.9% |
| Siemens |
2.8% |
| Nestle |
2.6% |
| JPMorgan European Discovery Trust Plc |
2.4% |
| Unicredit SPA |
2.4% |
| Allianz |
2.3% |
| Safran Sa |
2.1% |
| Total |
27.3% |
| Excludes Investments in Liquidity stocks |
|
| Name of contact and telephone number for queries: |
|
| Paul Ainger 0044 207 742 6524 |
|
| Name of authorised company official responsible for making this notification: |
|
| Paul Winship 0044 207 742 9815 - Company Secretary |
|
| Date: 10 September 2025 |
|
| |
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
[email protected] or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.